TESTOSTERONE ENANTHATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Testosterone Enanthate, and what generic alternatives are available?
Testosterone Enanthate is a drug marketed by Eugia Pharma, Hikma Farmaceutica, Nexus, Rising, Watson Labs, and Watson Pharms Inc. and is included in nine NDAs.
The generic ingredient in TESTOSTERONE ENANTHATE is estradiol valerate; testosterone enanthate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol valerate; testosterone enanthate profile page.
Summary for TESTOSTERONE ENANTHATE
Recent Clinical Trials for TESTOSTERONE ENANTHATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Texas Medical Branch, Galveston | Phase 2/Phase 3 |
North Florida/South Georgia Veterans Health System | Phase 2 |
North Florida Foundation for Research and Education | Phase 2 |
Pharmacology for TESTOSTERONE ENANTHATE
Drug Class | Androgen |
Mechanism of Action | Androgen Receptor Agonists |